Moderna tests multiple mRNA vaccines in one study

NCT ID NCT05397223

First seen Apr 02, 2026 · Last updated May 07, 2026 · Updated 4 times

Summary

This study tested several mRNA vaccines (for COVID-19, flu, RSV, and CMV) in 308 healthy adults aged 18 to 75. The main goal was to check safety and how well the vaccines triggered an immune response. Participants received one or more vaccines and were monitored for side effects and antibody levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Benchmark Research

    Austin, Texas, 78705, United States

  • CenExel

    Hollywood, Florida, 33024, United States

  • DM Clinical Research- Texas Center for Drug Development

    Houston, Texas, 77081, United States

  • Johnson County Clinical Trials

    Lenexa, Kansas, 66219, United States

  • Meridian Clinical Research

    Savannah, Georgia, 31406, United States

  • Meridian Clinical Research

    Sioux City, Iowa, 51106, United States

  • Meridian Clinical Research

    Lincoln, Nebraska, 68510, United States

  • Tekton Research, Inc

    Austin, Texas, 78745, United States

Conditions

Explore the condition pages connected to this study.